News Column

Research Results from East China University of Science and Technology Update Understanding of Apoptosis (Differential cytotoxicity and particle...

July 8, 2014

Research Results from East China University of Science and Technology Update Understanding of Apoptosis (Differential cytotoxicity and particle action of hydroxyapatite nanoparticles in human cancer cells)

By a News Reporter-Staff News Editor at Cancer Weekly -- Researchers detail new data in Apoptosis. According to news reporting from Shanghai, People's Republic of China, by NewsRx journalists, research stated, "While hydroxyapatite nanoparticles (HAPNs) have been reported to exhibit anticancer effects on several types of human cancer cells, no investigation has been performed to compare their cytotoxicity with different types of cancer cells. The objective of the present study is to investigate the cytotoxic action of HAPNs in different types of human cancer cell and to explore the possible mechanisms involved."

The news correspondents obtained a quote from the research from the East China University of Science and Technology, "Rod-shaped HAPNs were prepared by the aqueous precipitation method and then labeled with fluorescein isothiocyanate to visualize the cellular uptake and distribution. Their cytotoxicity to three human carcinoma cell lines (gastric cancer cells [MGC80-3], cervical adenocarcinoma epithelial cells [HeLa] and hepatoma cells [HepG2], as well as to normal human hepatocyte cells [L-02]) was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Cell apoptosis was characterized by the changes in nuclear morphology with 4',6-diamidino-2-phenylindole staining and by flow cytometric analysis with Annexin V-fluorescein isothiocyanate/propidium iodide double staining. Furthermore, the activity of apoptotic proteins (caspase-3, -8 and -9), intracellular reactive oxygen species and glutathione levels were analyzed in HAPN-treated cells. The cellular uptake of HAPNs was studied using flow cytometry analysis, and changes in intracellular calcium levels were investigated using the Ca(2+)-sensitive fluorescent dye, fluo-3 AM. HAPNs significantly inhibited cell proliferation and induced apoptosis of cancer cells with an order of MGC80-3 >HepG2 >HeLa, but had no impact on normal hepatic cells (L-02). The increase in apoptosis was accompanied by the activation of caspase-3 and -9, but not activation of caspase-8. Moreover, HAPN treatment led to reactive oxygen species generation and decreased intracellular glutathione in cancer cells, with the most remarkable reactive oxygen species burst in HeLa cells. The degree of cytotoxicity did not correlate with the cellular uptake efficiency of HAPNs. However, more HAPNs were found inside the nucleus of MGC80-3 cells, and an increase in the intracellular calcium level was observed in all cancer cells, with the highest level also detected in MGC80-3. Varying cytotoxicity of HAPNs was observed in different cancer cell types. Our results suggest that possible mechanisms of cytotoxicity in various types of cancer cells could be different."

According to the news reporters, the research concluded: "The elevated calcium concentration and nuclear localization of the particles might be the main mechanism of growth inhibition by HAPNs in cancer cells."

For more information on this research see: Differential cytotoxicity and particle action of hydroxyapatite nanoparticles in human cancer cells. Nanomedicine, 2014;9(3):397-412. (Elsevier -; Nanomedicine -

Our news journalists report that additional information may be obtained by contacting W. Tang, State Key Laboratory of Bioreactor Engineering, East China University of Science & Technology, Shanghai 200237, People's Republic of China. Additional authors for this research include Y. Yuan, C. Liu, Y. Wu, X. Lu and J. Qian (see also Apoptosis).

Keywords for this news article include: Asia, Cancer, Shanghai, Oncology, Apoptosis, Nanoparticle, Nanotechnology, Emerging Technologies, People's Republic of China.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Cancer Weekly

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters